First World Congress on

Mitochondria and Microbiota: Crucial Impact

October 17-18, 2024 - Corinthia Palace, Malta

Discussions will revolve around the dual role of EVs in mitochondrial function. They are instrumental in optimizing mitochondrial function by transferring proteins and genetic materials, which is vital for targeted drug delivery. However, they also pose risks by spreading damaged mitochondrial components, contributing to disease progression. The latest research in this field aims at biomarker discovery and regenerative approaches in mitochondrial medicine.

This segment will focus on microbiota-derived EVs and their significant role in health and disease. They facilitate communication among microorganisms and influence host cells, serving as potential biomarkers. These interactions between host-derived EVs and the microbiota offer promising therapeutic strategies for immune modulation, microbial balance restoration, and treating microbiota-related diseases.

Speakers Line-Up

Extracellular Vesicle Release of Mitochondria in Response to Lysosomal Dysfunction

Åsa B. Gustafsson, University of California San Diego, USA

Targeting central regulation of obesity with EVs: Breakthrough Approach Nature Metabolism

Ramaroson Andriantsitohaina, University of Montpellier, France

Bioinspired, Fully Synthetic Extracellular Vesicles to Optimize Wound Healing

Joachim Pius Spatz, University of Heidelberg, Germany

The Role of Mitovesicles in the Brain with Mitochondrial Dysfunction

Efrat Levy, NYU Grossman School of Medicine, USA

Cancer-related Extracellular Vesicles in relation to Mitochondria, Microbiota and More

Lorraine O’Driscoll, Trinity College Dublin and Trinity St. James's Cancer Institute, Ireland

Book Your Room at the Congress Hotel for Reduced Rate

Secure your accommodation now at the Congress Hotel, Corinthia Palace, for Targeting EVs 2024 at a discounted rate exclusively for attendees.

Targeting EVs 2024 Partner